Browse drugs

…2, and 34(29.8%) F3-F4 (severe fibrosis). All patients received ursodeoxycholic acid (UDCA) at 13 mg/kg. Regarding prediction of severe fibrosis, th…

…f stable therapy (food elimination diet, proton pump inhibitor, budesonide orodispersible tablets (BOTs), or combinations). All patients completed the Dysphagia …

…ing epithelioid granulomas, predominantly portal or periportal. Corticosteroids were the mainstay of therapy and led to biochemical and radiolo…

…rall mortality of 8.5%.Conclusion Mechanical thrombectomy using BOBBY BGC demonstrates high rates of FPE and overall success with a good …

…ion of the single longest empirical therapy with broad-spectrum antibiotics (6.77±0.55 days vs 10.29±1.15 days, p=0.007).Conclusions Pharma…

…er exposure (3 years) and newer-generation agents (semaglutide, tirzepatide) demonstrating the greatest reductions in risk of progression t…

…Ischaemic optic neuropathy was strongly associated with semaglutide, particularly Wegovy, in over 30 million FAERS reports. Signals…

…We aimed to examine the use of repeated visual stimulation with Gabor patches to improve vision.Methods A prospective randomised (3:1) contro…

… 2022, prevention was limited to the costly monoclonal antibody palivizumab. In August 2024, the UK introduced the RSVpreF (Abrysvo, Pfizer…

…5, CI 0.98 to 3.84) and FRIJEM (OR 1.70, CI 0.88 to 3.28). With ALOHA+, statistically significant positive associations were seen for …

… with most patients feeling uninvolved in decisions relating to medication and exercise regimens and their changes. A few, however, noted …

…Background Immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICIs) share symptomatic and therapeutic similarities with chro…